|
UBE2E3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.350400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.284420E-02 |
| Normal-vs-Stage2 |
5.743300E-03 |
| Normal-vs-Stage3 |
2.07099999999238E-05 |
| Normal-vs-Stage4 |
1.608920E-04 |
| Stage1-vs-Stage2 |
1.755050E-01 |
| Stage1-vs-Stage3 |
5.363900E-03 |
| Stage1-vs-Stage4 |
3.200500E-02 |
| Stage2-vs-Stage3 |
5.999200E-01 |
| Stage2-vs-Stage4 |
9.347400E-01 |
| Stage3-vs-Stage4 |
5.632800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.618500E-04 |
| Normal-vs-AfricanAmerican |
6.325900E-02 |
| Normal-vs-Asian |
1.673050E-01 |
| Caucasian-vs-AfricanAmerican |
2.983000E-01 |
| Caucasian-vs-Asian |
9.728600E-01 |
| AfricanAmerican-vs-Asian |
7.238800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.365500E-04 |
| Normal-vs-Female |
5.477600E-03 |
| Male-vs-Female |
1.651580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.782700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.423370E-03 |
| Normal-vs-Age(61-80Yrs) |
9.425500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.400300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.354800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.281400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.947600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.728800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.429200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.493000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.451200E-01 |
| Normal-vs-Grade 2 |
1.016630E-01 |
| Normal-vs-Grade 3 |
1.5155999999461E-07 |
| Normal-vs-Grade 4 |
1.56750000002148E-06 |
| Grade 1-vs-Grade 2 |
6.758400E-01 |
| Grade 1-vs-Grade 3 |
2.173900E-02 |
| Grade 1-vs-Grade 4 |
1.910260E-02 |
| Grade 2-vs-Grade 3 |
4.37420000000133E-05 |
| Grade 2-vs-Grade 4 |
2.596700E-04 |
| Grade 3-vs-Grade 4 |
2.295000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.656800E-01 |
| Normal-vs-ccB subtype |
2.04949999971227E-07 |
| ccA subtype-vs-ccB subtype |
5.0281999997015E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.622500E-04 |
| Normal-vs-N1 |
1.258740E-03 |
| N0-vs-N1 |
1.734960E-01 |
|
|
